0001203311-18-000081.txt : 20180904 0001203311-18-000081.hdr.sgml : 20180904 20180904205846 ACCESSION NUMBER: 0001203311-18-000081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180830 FILED AS OF DATE: 20180904 DATE AS OF CHANGE: 20180904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMPSON TODD E CENTRAL INDEX KEY: 0001216477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 181053722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-08-30 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001216477 SIMPSON TODD E 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Financial Officer Common Stock 2018-08-30 4 A 0 20715 0.0 A 194280 D Incentive Stock Option (right to buy) 76.86 2018-08-30 4 A 0 1301 0.0 A 2028-08-30 Common Stock 1301 1301 D Non-Qualified Stock Option (right to buy) 76.86 2018-08-30 4 A 0 47904 0.0 A 2028-08-30 Common Stock 47904 47904 D These shares represent restricted stock units and will be settled in common stock upon vesting. Shares shall vest at a rate of 25% on each anniversary of the grant date until all shares are fully vested four years from the grant date. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares shall vest at a rate of 25% one year from the grant date and monthly thereafter until all shares are fully vested four years from the grant date. By: /s/ Jean Liu For: Todd E. Simpson 2018-09-04